NOGAPENDEKIN ALFA INBAKICEPT-PMLN

NOGAPENDEKIN ALFA INBAKICEPT-PMLN was reported 49 times

NOGAPENDEKIN ALFA INBAKICEPT-PMLN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLUORESCENT IN SITU HYBRIDISATION POSITIVE 1 0.1000
1 PERITONEAL CARCINOMA METASTATIC 1 0.0159
2 CYTOLOGY ABNORMAL 1 0.0067
3 METASTATIC CARCINOMA OF THE BLADDER 2 0.0056
4 PENILE BURNING SENSATION 1 0.0035
5 UROGENITAL HAEMORRHAGE 1 0.0027
6 FAECAL VOLUME DECREASED 1 0.0021
7 BLADDER CANCER RECURRENT 2 0.0020
8 PERINEAL PAIN 1 0.0014
9 BLADDER PAIN 4 0.0013
10 BLADDER SPASM 2 0.0011
11 HAEMORRHAGE URINARY TRACT 1 0.0004
12 MUCOUS STOOLS 1 0.0002
13 NEUROLOGICAL SYMPTOM 1 0.0002
14 DYSURIA 5 0.0001
15 MYASTHENIA GRAVIS 1 0.0001
16 POLLAKIURIA 5 0.0001
17 BLOOD URINE PRESENT 2 0.0001
18 BLADDER DISORDER 1 0.0001
19 HAEMATURIA 3 0.0001
20 MICTURITION URGENCY 1 0.0001
21 ABDOMINAL PAIN LOWER 2 0.0001
22 NEUTROPENIA 10 0.0001
23 DEVICE FAILURE 1 0.0001
24 CHILLS 7 0.0001
25 PELVIC PAIN 1 0.0001
26 MENTAL STATUS CHANGES 1 0.0000
27 BLOOD CREATININE INCREASED 2 0.0000
28 URINARY RETENTION 1 0.0000
29 BURNING SENSATION 2 0.0000
30 INFLUENZA LIKE ILLNESS 2 0.0000
31 ROAD TRAFFIC ACCIDENT 1 0.0000
32 URINARY TRACT INFECTION 4 0.0000
33 ANAEMIA 4 0.0000
34 THERAPY CESSATION 1 0.0000
35 ABDOMINAL DISTENSION 2 0.0000
36 HYPONATRAEMIA 1 0.0000
37 FLATULENCE 1 0.0000
38 PYREXIA 6 0.0000
39 UNDERDOSE 1 0.0000
40 HALLUCINATION 1 0.0000
41 UNEVALUABLE EVENT 1 0.0000
42 ADVERSE DRUG REACTION 1 0.0000
43 SWELLING 1 0.0000
44 GAIT DISTURBANCE 2 0.0000
45 ILLNESS 1 0.0000
46 SEPSIS 1 0.0000
47 PERIPHERAL SWELLING 1 0.0000
48 CONFUSIONAL STATE 1 0.0000
49 ABDOMINAL DISCOMFORT 1 0.0000
50 NAUSEA 4 0.0000
51 ERYTHEMA 1 0.0000
52 ARTHRALGIA 2 0.0000
53 MALAISE 2 0.0000
54 INSOMNIA 1 0.0000
55 WEIGHT DECREASED 1 0.0000
56 PAIN 2 0.0000
57 PNEUMONIA 1 0.0000
58 ASTHENIA 1 0.0000
59 DRUG INEFFECTIVE 3 0.0000
60 OFF LABEL USE 1 0.0000